AN2 Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANTX and other ETFs, options, and stocks.About ANTX
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases.
CEOEric Easom
CEOEric Easom
Employees22
Employees22
HeadquartersMenlo Park, California
HeadquartersMenlo Park, California
Founded2017
Founded2017
Employees22
Employees22
ANTX Key Statistics
Market cap30.01M
Market cap30.01M
Price-Earnings ratio-0.97
Price-Earnings ratio-0.97
Dividend yield—
Dividend yield—
Average volume70.23K
Average volume70.23K
High today$1.11
High today$1.11
Low today$1.05
Low today$1.05
Open price$1.11
Open price$1.11
Volume79.65K
Volume79.65K
52 Week high$1.59
52 Week high$1.59
52 Week low$1.01
52 Week low$1.01
Stock Snapshot
AN2 Therapeutics(ANTX) stock is priced at $1.10, giving the company a market capitalization of 30.01M. It carries a P/E multiple of -0.97.
On 2025-12-08, AN2 Therapeutics(ANTX) stock traded between a low of $1.05 and a high of $1.11. Shares are currently priced at $1.10, which is +4.8% above the low and -0.9% below the high.
The AN2 Therapeutics(ANTX)'s current trading volume is 79.65K, compared to an average daily volume of 70.23K.
During the past year, AN2 Therapeutics(ANTX) stock moved between $1.01 at its lowest and $1.59 at its peak.
During the past year, AN2 Therapeutics(ANTX) stock moved between $1.01 at its lowest and $1.59 at its peak.
People also own
Based on the portfolios of people who own ANTX. This list is generated using Robinhood data, and it’s not a recommendation.